208 related articles for article (PubMed ID: 21098035)
1. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
[TBL] [Abstract][Full Text] [Related]
3. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.
Lee CJ; Lee HS; Ryu HW; Lee MH; Lee JY; Li Y; Dong Z; Lee HK; Oh SR; Cho YY
Carcinogenesis; 2014 Feb; 35(2):432-41. PubMed ID: 24031026
[TBL] [Abstract][Full Text] [Related]
4. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of H2AX at Ser139 and a new phosphorylation site Ser16 by RSK2 decreases H2AX ubiquitination and inhibits cell transformation.
Zhu F; Zykova TA; Peng C; Zhang J; Cho YY; Zheng D; Yao K; Ma WY; Lau AT; Bode AM; Dong Z
Cancer Res; 2011 Jan; 71(2):393-403. PubMed ID: 21224359
[TBL] [Abstract][Full Text] [Related]
6. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.
Lee CJ; Lee MH; Yoo SM; Choi KI; Song JH; Jang JH; Oh SR; Ryu HW; Lee HS; Surh YJ; Cho YY
BMC Cancer; 2015 Aug; 15():576. PubMed ID: 26253302
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of histone H2B serine 32 is linked to cell transformation.
Lau AT; Lee SY; Xu YM; Zheng D; Cho YY; Zhu F; Kim HG; Li SQ; Zhang Z; Bode AM; Dong Z
J Biol Chem; 2011 Jul; 286(30):26628-37. PubMed ID: 21646345
[TBL] [Abstract][Full Text] [Related]
8. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.
Kim HG; Lee KW; Cho YY; Kang NJ; Oh SM; Bode AM; Dong Z
Cancer Res; 2008 Apr; 68(7):2538-47. PubMed ID: 18381464
[TBL] [Abstract][Full Text] [Related]
9. Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G
Choi JS; Cho YY
Biochem Biophys Res Commun; 2023 Jan; 642():66-74. PubMed ID: 36566564
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
11. ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression.
Gupta P; Prywes R
J Biol Chem; 2002 Dec; 277(52):50550-6. PubMed ID: 12414794
[TBL] [Abstract][Full Text] [Related]
12. RSK2 and its binding partners in cell proliferation, transformation and cancer development.
Cho YY
Arch Pharm Res; 2017 Mar; 40(3):291-303. PubMed ID: 28013489
[TBL] [Abstract][Full Text] [Related]
13. p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.
He Z; Cho YY; Liu G; Ma WY; Bode AM; Dong Z
J Biol Chem; 2003 Jul; 278(29):26435-42. PubMed ID: 12748197
[TBL] [Abstract][Full Text] [Related]
14. A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.
Cho YY; Yao K; Pugliese A; Malakhova ML; Bode AM; Dong Z
Cancer Res; 2009 May; 69(10):4398-406. PubMed ID: 19435896
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
[TBL] [Abstract][Full Text] [Related]
16. The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling.
Lopez J; Bonsor DA; Sale MJ; Urisman A; Mehalko JL; Cabanski-Dunning M; Castel P; Simanshu DK; McCormick F
J Biol Chem; 2023 Jun; 299(6):104789. PubMed ID: 37149146
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
Kang S; Dong S; Gu TL; Guo A; Cohen MS; Lonial S; Khoury HJ; Fabbro D; Gilliland DG; Bergsagel PL; Taunton J; Polakiewicz RD; Chen J
Cancer Cell; 2007 Sep; 12(3):201-14. PubMed ID: 17785202
[TBL] [Abstract][Full Text] [Related]
18. RSK2 as a key regulator in human skin cancer.
Cho YY; Lee MH; Lee CJ; Yao K; Lee HS; Bode AM; Dong Z
Carcinogenesis; 2012 Dec; 33(12):2529-37. PubMed ID: 22918890
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.
Peng C; Zhu F; Wen W; Yao K; Li S; Zykova T; Liu K; Li X; Ma WY; Bode AM; Dong Z
J Biol Chem; 2012 Jul; 287(31):25881-92. PubMed ID: 22685297
[TBL] [Abstract][Full Text] [Related]
20. The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.
Lee KW; Kang NJ; Rogozin EA; Oh SM; Heo YS; Pugliese A; Bode AM; Lee HJ; Dong Z
Int J Cancer; 2008 Dec; 123(11):2487-96. PubMed ID: 18767048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
